WorthPointe LLC Buys New Position in HCA Healthcare, Inc. (NYSE:HCA)

WorthPointe LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, Holdings Channel.com reports. The fund purchased 529 shares of the company’s stock, valued at approximately $215,000.

A number of other institutional investors have also added to or reduced their stakes in HCA. FMR LLC raised its stake in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Lee Danner & Bass Inc. bought a new position in HCA Healthcare during the second quarter valued at $131,527,000. Darsana Capital Partners LP lifted its position in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the last quarter. Swedbank AB purchased a new stake in HCA Healthcare in the 1st quarter worth about $95,882,000. Finally, Argent Capital Management LLC increased its stake in shares of HCA Healthcare by 1,215.6% in the second quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock worth $51,493,000 after purchasing an additional 148,092 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $328.95 on Wednesday. The firm has a market cap of $83.32 billion, a price-to-earnings ratio of 14.77, a PEG ratio of 1.25 and a beta of 1.68. The company has a 50-day simple moving average of $376.47 and a two-hundred day simple moving average of $358.74. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12-month low of $245.84 and a 12-month high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.80%. HCA Healthcare’s payout ratio is currently 11.85%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on HCA shares. Barclays dropped their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Finally, Morgan Stanley started coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $380.29.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 over the last three months. 1.70% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.